Currently, one of the most recent and promising methods to treat T2DM is to use dipeptidyl peptidase 4 (DPP-4) inhibitors, which are also called gliptins [4,5,6,7,8,9]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.